Abstract: Provided is a compound comprising a first ligand LA of where at least one of RA and RB is a structure of

Abstract: A compound comprising a first bidentate ligand LA having a structure of Formula I, is provided. In Formula I, each of Y1 to Y12 is CR or N; each R can be same or different; each R is hydrogen or a substituent; at least one pair selected from Y3-Y4, Y7-Y8, or Y11-Y12 are CR and the Rs are joined or fused into a ring; and LA is complexed to a metal M selected from the group consisting of Os, Ir, Pd, and Pt. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: The present invention relates in part to compounds containing indolocarbazole and terphenyl building blocks. These compounds are useful for application in organic electroluminescent devices wherein the combination of indolocarbazoles with terphenyl groups leads to novel compounds that demonstrate superior device performance.

Abstract: A compound having a first ligand LA of Formula I, is provided. In Formula I, Z is C or N; at least one of X1 to X5 is N, and the remainder are C; if X1 is N, then X5 is C; K is selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); each R?, R?, RA and RB is a hydrogen or a General Substituent; LA is coordinated to a metal M; and Ring A coordinates to M through a metal carbene bond. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A composition including a first compound capable of functioning as a phosphorescent emitter in an OLED is provided. The first compound has at least one aromatic ring and at least one substituent R directly bonded to one of the at least one aromatic rings. Each substituent R has the formula of where (a) G1 is selected from NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; and G2 is a non-aromatic polycyclic group; (b) G1 is a direct bond; and G2 is a non-aromatic spiro polycyclic group; or (c) G1 is selected from direct bond, NR1, SiR1R2, GeR1R2, alkyl, cycloalkyl, and combinations thereof; G2 is a non-aromatic polycyclic group; and R is directly bonded to a phenyl, pyridine, or triazine. R1, R2, and R3 are are a variety of substituents. Formulations and devices, such as an OLEDs, that include the first compound are also described.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, rings A and B are 5- or 6-membered ring; K1 and K2 are each independently selected from the group consisting of a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), and Si(R?)(R?); Z1, Z2, X1 and X2 are C or N; Y1*, Y2*, Y3*, Y4*, and Y5* are selected from a variety of moieties; n is 0 or 1; Y5* is bonded directly to X2 when n is 0; each R?, R?, R, R?, R1, R2, RA, and RB is hydrogen or a substituent; each independently represents a single bond or double bond in a Lewis structure; and LA is coordinated to a metal M, which may be coordinated to other ligands. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: An OLED including an anode, a cathode, and an organic layer between the anode and the cathode, where the organic layer includes a compound having the formula [LA]3-nIr[LB]n is disclosed.

Abstract: Provided is a compound having a formula of Ir(LA*)m(LB*)n(LC*)p; wherein each LA, LB, and LC is independently a monoanionic bidentate ligand and different from each other; n and p each is independently 0, 1, or 2; m is 1 or 2; and m+n+p is 3; a free-state of LA has a first triplet energy T1 of EA at 77K; a free-state of LB has a first triplet energy T1 of EB at 77K; a free-state of LC has a first triplet energy T1 of EC at 77K; EA is less than EB and EC whichever EB and EC is present; LA comprises at least one ?-electron deficient electron-withdrawing group; and the compound has an emission spectrum with a FWHM value of no more than 45 nm. Also provided is a compound comprising a first ligand LA having a structure of Formula I, wherein the variables are defined herein.

Abstract: Provided is a compound of Formula of Ir(LA)n(LB)m(LC)o, wherein ligand LA has a structure of Formula I, ligand LB has a structure of Formula II, and LC is a bidentate ligand; and wherein n is 1, or 2; m is 1, or 2; o is 0, or 1; and n+m+o=3; and all the remaining variables are defined herein. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, each of X1 to X12 is C or N; Y is a linking group; each RA, RB and RC can be hydrogen or a substituent; at least one RA, RB or RC comprises an electron-withdrawing group; and LA forms a 5-membered chelate ring with an Ir atom via the dashed lines. In addition a number of conditions must be met based on whether or not any pair of RA is joined to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound having the formula Ir(LA)n(LB)3-n, having the structure of Formula I is provided. In the structure of Formula I, each of A1 through A8 is independently carbon or nitrogen; at least one of A1 through A8 is nitrogen; ring B is bonded to ring A through a C—C bond; the iridium is bonded to ring A through an Ir—C bond; X is O, S, or Se; each of R1 through R5 are independently selected from a variety of substituents, which may be linked for form a ring; n is an integer from 1 to 3; and at least one R2 adjacent to ring C is not hydrogen. Formulations and devices, such as OLEDs, that include the first compound are also provided.

Abstract: A compound having a metal coordination complex structure, where the compound is capable of functioning as a phosphorescent emitter in an organic light emitting device at room temperature is disclosed. The compound has a first ligand coordinated to a metal. The free-state of the first ligand has a first triplet energy T1 of EL at 77K, while the compound has a first triplet energy T1 of E at 77K, and the difference in energy (?E) between E and EL is ?250 meV. The compound has a triplet emission spectrum with a FWHM value of no more than 45 nm. Organic light emitting devices, consumer products, and formulations containing the compounds are also disclosed.

Abstract: A compound including a first ligand LX of Formula II is disclosed, where F is a 5-membered or 6-membered carbocyclic or heterocyclic ring; each RF and RG independently represents mono to the maximum possible number of substitutions, or no substitution; Z3 and Z4 are each independently C or N and coordinated to a metal M to form a 5-membered chelate ring; G is a fused ring structure comprising five or more fused heterocyclic or carbocyclic rings, of which one or two rings are of Formula III the fused heterocyclic or carbocyclic rings in the fused ring structure G are 5-membered or 6-membered; of which if two or more 5-membered rings are present, at least two of the 5-membered rings are fused to one another; Y can be one of BR?, NR?, PR?, O, S, Se, C?O, S?O, SO2, CR?R?, SiR?R?, and GeR?R?; the metal M can be coordinated to other ligands; and the ligand LX can be linked with other ligands to comprise a tridentate, tetradentate, pentadentate, or hexadentate ligand.

Abstract: A compound having the formula: Formula I is disclosed. The compound is useful as emitters in OLEDs.

Abstract: A compound having the formula [LA]yIr[LB]x is disclosed, where LA is selected from one of the following: The compounds have at least one pyridyl dibenzo-substituted ligand that coordinates to metal center from the sterically hindered position as exemplified by LA. Because of this unique configuration, the compounds display better photo-physical and thermal properties and can be used in OLED devices to improve their performance, particularly with respect to the device's lifetime.

Abstract: The present invention includes organic compounds with two substituted triazine, pyridine, pyrimidine or pyrazine rings attached to an aromatic or heteroaromatic ring system. The compounds are expected to improve OLED performance.

Abstract: A compound comprising a ligand LA, having a structure of Formula I, is provided. In Formula I, A1 to A8 are each independently CR or N; at least two adjacent ones of A1 to A8 are CR and the Rs are joined together to form a six-membered ring fused to ring A or ring C; X is O, S, or Se; each R and RB is independently hydrogen or a substituent; any adjacent substituents are optionally joined or fused into a ring; the ligand LA is coordinated to a metal M; the metal M is bonded to ring A through a M-C bond; the metal M can be coordinated to other ligands; and the ligand LA is optionally linked with other ligands. Formulations, OLEDs, and consumer products containing such compounds are also disclosed.

Abstract: An OLED including an anode, a cathode, and an organic layer between the anode and the cathode, where the organic layer includes a compound having the formula [LA]3-nIr[LB]n is disclosed.

Abstract: A compound having the formula (LA)mIr(LB)3-m, where LA is and LB is is disclosed. In the formula (LA)mIr(LB)3-m, LA and LB are different; each of X1 to X5 is C—RF or nitrogen; X is selected from O, S, and Se; each R1, R2, RB, RD, and RF is hydrogen or a substituent; R3 is alkyl, cycloalkyl, or a combination thereof; and m is 1 or 2. OLEDs, consumer products, and formulations including the compound are also disclosed.

Abstract: A compound having the formula Ir(LA)n(LB)3-n, having the structure of Formula I is provided. In the structure of Formula I, each of A1 through A8 is independently carbon or nitrogen; at least one of A1 through A8 is nitrogen; ring B is bonded to ring A through a C—C bond; the iridium is bonded to ring A through an Ir—C bond; X is O, S, or Se; each of R1 through R5 are independently selected from a variety of substituents, which may be linked for form a ring; n is an integer from 1 to 3; and at least one R2 adjacent to ring C is not hydrogen. Formulations and devices, such as OLEDs, that include the first compound are also provided.